History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Cycle for Survival Fred's Team Rock & Run on the River Yankees Universe Fund Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck CELEBRATIONS
Press Releases In the News Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment
Newly Diagnosed?
We Can Help
Newly Diagnosed? We Can Help
Information for those newly diagnosed with leukemia

If you or your loved one has been diagnosed with chronic lymphocytic leukemia (CLL), Memorial Sloan-Kettering Cancer Center is ready to help. Our experienced team of doctors, nurses, and other healthcare professionals who treat CLL is dedicated to providing the highest-quality treatment and care for patients with this disease. Our patients also have access to innovative therapies through our clinical trials.

  • Overview
    Chronic lymphocytic leukemia is one of the most common forms of leukemia in adults.
  • Risk Factors
    Risk factors for developing CLL can include inherited, or genetic, traits and exposure to cancer-causing agents in the environment. There is only a very small chance that a person who has one of the few known risk factors for CLL will develop the disease.
  • Symptoms
    When CLL first develops, patients may not have any symptoms, and this phase may last for several years. CLL is often discovered when people with the disease have routine blood tests during a regular checkup.
  • Diagnosis
    Physicians perform an array of tests to diagnose CLL and determine both its type and subtype.
  • Classification
    Physicians designate CLL patients as low risk (stage 0), intermediate risk (stages I and II), or high risk (stages III and IV).
  • Treatment
    Physicians devise a course of treatment for each CLL patient based on the stage and symptoms of the disease and the patient's age and overall health.
  • Follow-Up Care
    People with CLL are likely to see their physician often to monitor whether or not the disease is progressing.

Bookmark and SharePrintEmail This Page